Komori
M&A and Subsidiary Changes3788GMO GlobalSign Holdings K.K.Information and Communications, Services and Others

(Update on Disclosed Matter) Notice Concerning the Recognition of an Extraordinary Gain in Connection with the Transfer of Shares in a Consolidated Subsidiary

In connection with the transfer of shares in GMOデジタルラボ株式会社 completed on 1 July 2026, the Company expects to recognize an extraordinary gain of ¥440.476 million in the third quarter of the fiscal year ending December 2026.

Worth reading
52Recurring
Scored from 2 of 5 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
440476
¥ thousand
Wording
Avoiding a definitive answer
How definitive the wording is.

This transaction

Share transfer
Disclosing companyGMO GlobalSign Holdings K.K.
GMO Digital Lab Inc.Subject of this transaction
Execution Date / Effective Date1 July 2026 (already implemented)
Consideration and expenses
Amount of extraordinary income (loss)Extraordinary gain: ¥440,476 thousand; consolidated accounting period for the third quarter of the fiscal year ending December 2026
Impact on Business Performance

The consolidated earnings forecast for the fiscal year ending December 2026 remains unchanged at present. If a revision becomes necessary, the Company will promptly disclose it.

This transaction
ItemDetails
Transaction nameShare transfer
Name of the Subject CompanyGMO Digital Lab Inc.
Amount of extraordinary income (loss)Extraordinary gain: ¥440,476 thousand; consolidated accounting period for the third quarter of the fiscal year ending December 2026
Impact on Business PerformanceThe consolidated earnings forecast for the fiscal year ending December 2026 remains unchanged at present. If a revision becomes necessary, the Company will promptly disclose it.
Execution Date / Effective Date1 July 2026 (already implemented)
Items this document does not state (27)
Counterparty nameBusiness Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredVoting rights ownership percentageFunding arrangementsGoodwill amountDate of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The share transfer agreement includes an earn-out provision under which additional consideration will be received based on the target company's future performance and other factors, and this consideration will be recognized as part of the extraordinary gain.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
(Update on Disclosed Matter) Notice Concerning the Recognition of an Extraordinary Gain in Connection with the Transfer of Shares in a Consolidated Subsidiary | GMO GlobalSign Holdings K.K. (3788) timely disclosure | Komori